Related references
Note: Only part of the references are listed.MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer
Hiroshi Hirata et al.
CARCINOGENESIS (2012)
Chemoresistance to Temozolomide in Human Glioma Cell Line U251 is Associated with Increased Activity of O 6-methylguanine-DNA Methyltransferase and Can be Overcome by Metronomic Temozolomide Regimen
Qiang Pan et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
被撤回的出版物: Anti-microRNA-222 (Anti-miR-222) and-181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal (Retracted article. See vol. 293, pg. 3588, 2018)
Yuanzhi Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
Shyamal D. Weeraratne et al.
NEURO-ONCOLOGY (2011)
MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
Atsushi Sato et al.
STEM CELLS (2011)
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
Zhongxing Liang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma
Feng Zhi et al.
EUROPEAN JOURNAL OF CANCER (2010)
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
Igor P. Pogribny et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Wei Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients
O. Slaby et al.
NEOPLASMA (2010)
Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin
Guo-Qing Chen et al.
MEDICAL ONCOLOGY (2010)
TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
B. Wang et al.
ONCOGENE (2010)
Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance
Fuxiao Xin et al.
BIOINFORMATICS (2009)
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme
Yiming Li et al.
BRAIN RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Tumour cell survival signalling by the ERK1/2 pathway
K. Balmanno et al.
CELL DEATH AND DIFFERENTIATION (2009)
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors
Alfredo Conti et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Polyploidy in atypical grade II choroid plexus papilloma of the posterior fossa
Maria Sol Brassesco et al.
NEUROPATHOLOGY (2009)
MicroRNAs as potential cancer therapeutics
P Trang et al.
ONCOGENE (2009)
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Yasunori Fujita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
IFN-γ-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation
Annabel F. Valledor et al.
BLOOD (2008)
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells
Lei Shi et al.
BRAIN RESEARCH (2008)
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
David T. W. Jones et al.
CANCER RESEARCH (2008)
Role of microRNAs in drug-resistant ovarian cancer cells
Antonio Sorrentino et al.
GYNECOLOGIC ONCOLOGY (2008)
MicroRNA-221/222 Negatively Regulates Estrogen Receptor α and Is Associated with Tamoxifen Resistance in Breast Cancer
Jian-Jun Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Olga Kovalchuk et al.
MOLECULAR CANCER THERAPEUTICS (2008)
MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications
M. Fabbri et al.
LEUKEMIA (2008)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies
Xiaozhong Qian et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
Fanyin Meng et al.
GASTROENTEROLOGY (2006)
Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme
H Athanassiou et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival
W Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
ME Hegi et al.
CLINICAL CANCER RESEARCH (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
